Transgene-mediated suppression of dengue viruses in the salivary glands of the yellow fever mosquito, Aedes aegypti

Insect Mol Biol. 2010 Dec;19(6):753-63. doi: 10.1111/j.1365-2583.2010.01032.x.

Abstract

Controlled sex-, stage- and tissue-specific expression of antipathogen effector molecules is important for genetic engineering strategies to control mosquito-borne diseases. Adult female salivary glands are involved in pathogen transmission to human hosts and are target sites for expression of antipathogen effector molecules. The Aedes aegypti 30K a and 30K b genes are expressed exclusively in adult female salivary glands and are transcribed divergently from start sites separated by 263 nucleotides. The intergenic, 5'- and 3'-end untranslated regions of both genes are sufficient to express simultaneously two different transgene products in the distal-lateral lobes of the female salivary glands. An antidengue effector gene, membranes no protein (Mnp), driven by the 30K b promoter, expresses an inverted-repeat RNA with sequences derived from the premembrane protein-encoding region of the dengue virus serotype 2 genome and reduces significantly the prevalence and mean intensities of viral infection in mosquito salivary glands and saliva.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aedes / genetics
  • Aedes / virology*
  • Animals
  • Animals, Genetically Modified / genetics
  • Animals, Genetically Modified / virology*
  • Cell Line
  • Dengue Virus / genetics
  • Dengue Virus / physiology*
  • Female
  • Gene Expression Regulation
  • Gene Order / genetics
  • Haplorhini
  • Insect Vectors / genetics
  • Insect Vectors / virology*
  • Male
  • RNA / genetics
  • RNA / metabolism
  • Salivary Glands / virology
  • Sex Factors
  • Transgenes / genetics*

Substances

  • RNA